Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Observational × von Hippel-Lindau Disease × Clear all

Status

Recruiting 7 Completed 5 Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 61 Neoplasms 54 Prostatic Neoplasms 43 Lung Neoplasms 30 Carcinoma, Non-Small-Cell Lung 24 Colorectal Neoplasms 18 Carcinoma, Hepatocellular 15 Pancreatic Neoplasms 14 Colonic Neoplasms 13 Carcinoma, Renal Cell 13 Leukemia, Myeloid, Acute 12 Head and Neck Neoplasms 12 Brain Neoplasms 12 Ovarian Neoplasms 11 Melanoma 11 Lymphoma 11 Hematologic Neoplasms 10 Uterine Cervical Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Neoplasm Metastasis 9 Lymphoma, Non-Hodgkin 9 Liver Neoplasms 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Stomach Neoplasms 7 Papillomavirus Infections 7 Multiple Myeloma 7 Glioblastoma 7 Rectal Neoplasms 6 Leukemia 6 Leiomyoma 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06554730 2024-11-29

MK-6482-026

Merck Sharp & Dohme LLC

von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡